Computational Oncology in the Multi-Omics Era: State of the Art

Cancer is the quintessential complex disease. As technologies evolve faster each day, we are able to quantify the different layers of biological elements that contribute to the emergence and development of malignancies. In this multi-omics context, the use of integrative approaches is mandatory in o...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 10; p. 423
Main Authors de Anda-Jáuregui, Guillermo, Hernández-Lemus, Enrique
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer is the quintessential complex disease. As technologies evolve faster each day, we are able to quantify the different layers of biological elements that contribute to the emergence and development of malignancies. In this multi-omics context, the use of integrative approaches is mandatory in order to gain further insights on oncological phenomena, and to move forward toward the precision medicine paradigm. In this review, we will focus on computational oncology as an integrative discipline that incorporates knowledge from the mathematical, physical, and computational fields to further the biomedical understanding of cancer. We will discuss the current roles of computation in oncology in the context of multi-omic technologies, which include: data acquisition and processing; data management in the clinical and research settings; classification, diagnosis, and prognosis; and the development of models in the research setting, including their use for therapeutic target identification. We will discuss the machine learning and network approaches as two of the most promising emerging paradigms, in computational oncology. These approaches provide a foundation on how to integrate different layers of biological description into coherent frameworks that allow advances both in the basic and clinical settings.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Raoul Jean Pierre Bonnal, Istituto Nazionale Genetica Molecolare (INGM), Italy; Barbara Di Camillo, University of Padova, Italy; Dietmar Rieder, Innsbruck Medical University, Austria
This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology
Edited by: Francesca Finotello, Innsbruck Medical University, Austria
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2020.00423